Skip to main content
. 2015 Sep 28;132(13):1252–1260. doi: 10.1161/CIRCULATIONAHA.115.015710

Table 1.

Dabigatran- and VKA-Matched–Treated Patients: Baseline Characteristics According to Treatment Group After Propensity Score Matching

graphic file with name cir-132-1252-g002.jpg